TD2 Oncology
Scottsdale, AZ, United States td2inc.com
From their website, Nov 2026
Work here? Claim this listing
About
TD2 Oncology is an oncology contract research organization that supports drug development from preclinical work through clinical trial management and regulatory support. It serves biotech and pharmaceutical sponsors developing oncology therapies, including radiopharmaceuticals, hematologic malignancies, antibody-drug conjugates, small molecules, and cancer vaccines. The company is based in Scottsdale, Arizona.
Services
Clinical trial services
Provides Phase I, II, and III clinical trial design, planning, execution, data analysis, and final reporting for oncology studies.
Assays & in vitro testing
Study design & protocol development
Develops oncology trial protocols and study designs tailored to the therapy and indication.
Assays & in vitro testing
Patient identification and site engagement
Identifies patients and engages study sites for oncology clinical trials.
Assays & in vitro testing
Site management and monitoring
Manages and monitors clinical sites during oncology trials.
Assays & in vitro testing
Strategic third-party vendor management
Coordinates third-party vendors supporting clinical trial operations.
Assays & in vitro testing
Biostatistics
Provides statistical support for clinical trial design and analysis.
Assays & in vitro testing
Data management
Manages clinical trial data collection, organization, and analysis.
Assays & in vitro testing
Clinical flow cytometry
Performs flow cytometry services for oncology clinical trials and translational work.
Assays & in vitro testing
Pharmacovigilance
Supports safety monitoring and adverse event oversight for clinical trials.
Assays & in vitro testing
Medical monitoring services
Provides oncology-focused medical oversight, real-time patient safety review, and protocol deviation management.
Assays & in vitro testing
eTMF management
Manages electronic trial master files and trial documentation for regulatory readiness.
Assays & in vitro testing
Quality assurance
Conducts audits and quality management activities to support trial compliance and integrity.
Assays & in vitro testing
Translational regulatory services
Provides regulatory planning, consulting, and translational support for oncology development programs.
Regulatory & medical writing
Prepares regulatory and medical writing deliverables for oncology programs and submissions.
Gap analysis & roadmap development
Assesses development packages, identifies missing elements, and builds a roadmap toward FDA submission and clinic entry.
Protocol design
Designs protocols for oncology development programs, including translational and clinical work.
Program budget & timeline
Builds program budgets and timelines for development planning.
Preclinical model systems
Offers syngeneic, orthotopic, PDX, humanized mouse, diet-induced obesity tumor, adoptive cell therapy, and CDX models.
Bioanalytical services
Provides bioanalytical support for preclinical oncology studies.
Assays & in vitro testing
Preclinical flow cytometry
Offers flow cytometry analysis for preclinical studies, including immunophenotyping and biomarker evaluation.
Assays & in vitro testing
Metabolomics and proteomics analysis
Performs metabolomic and proteomic analysis for preclinical and early clinical oncology studies.
Assays & in vitro testing
DMPK/ADME services
Provides drug metabolism, pharmacokinetics, and absorption, distribution, metabolism, and excretion support.
ADME, DMPK & toxicology
In vivo and in vitro characterization
Characterizes investigational compounds in vivo and in vitro for oncology programs.
Assays & in vitro testing
In vivo optical imaging
Uses optical imaging to monitor tumor growth kinetics and disease progression in preclinical models.
Assays & in vitro testing
Therapeutic evaluation
Evaluates therapeutic response in preclinical oncology studies.
Assays & in vitro testing
PK/ADME
Provides pharmacokinetic and ADME support, including PK, PD, and biomarker analyses.
ADME, DMPK & toxicology
Clinical trial services for radiopharmaceuticals
Supports radiopharmaceutical trial design, regulatory strategy, site feasibility, and clinical execution.
Assays & in vitro testing
Clinical trial services for hematologic malignancies
Supports hematology-oncology trials for leukemia, lymphoma, multiple myeloma, AML, MDS, and myelofibrosis.
Assays & in vitro testing
Clinical trial services for antibody-drug conjugates
Supports ADC clinical trials with trial design, bioanalytics, and safety monitoring.
Assays & in vitro testing
Clinical trial services for small molecules
Supports small molecule oncology development from first-in-human through regulatory approval.
Assays & in vitro testing
- What to send
- Biological samples: plasma, serum, tissues · Tissues including tumor, brain, heart, kidneys, lungs, muscles · Whole blood, bone marrow, spleen, and tumor · PBMC services
Capabilities
- Assays and studies
- Flow cytometry · ADCs · Antibodies · ADME · In vivo · Cell therapy · Small molecules · Bioanalysis · Rodent models · Biostatistics · Pharmacovigilance · Medical monitoring
13 more
PK/PD analysis · Metabolomics · Proteomics · DMPK · Optical imaging · LC-MS/MS · UV-VIS · PAMPA · Caco-2 · CYP phenotyping · Clinical flow cytometry · Preclinical flow cytometry · PK/ADME - Scale and capacity
- Over 400 models of cancer · AAALAC-accredited vivarium
- Therapeutic areas
- Radiopharmaceuticals · Hematologic malignancies · Antibody-drug conjugates · Small molecules · Cancer vaccine development · Oncology · Autoimmune disease · Allergy · Inflammatory disorders
Instruments and platforms
- Waters Xevo TQ-S
- Acquity I-class UPLC system
- Spectral Instruments Imaging AMI HTX
- Aura imaging software 4.0
- Phoenix WinNonlin software
- PET
- SPECT
Modalities and species
- Modalities
- Small molecule · Antibody · ADC · Cell therapy · Vaccine
- Species and models
- Syngeneic tumor models · Orthotopic tumor models · Patient derived xenograft (PDX) models · Humanized mouse models · Diet-induced obesity tumor model · Adoptive cell therapy models · Cell line derived xenografts (CDX) · Mouse · PBMC · Whole blood · Bone marrow · Spleen
6 more
Tumors · Lymph nodes · Patient-derived xenograft (PDX) models · Cell line derived xenografts (CDX) models · PET · SPECT
Industries served
- Biotech
- Pharmaceutical
- Oncology
Company
- Type
- CRO
- Founded
- 2003
- Quality
- AAALAC-accredited (vivarium) · GCP (clinical trial activities) · GCP (Good Clinical Practice)
Locations
- Address
- 13208 E. Shea Blvd, Suite 100 Scottsdale, AZ 85259
- Sites
- Scottsdale, United States
- Serves
- global
Contacts
- Phone
- (602) 358-8300
Similar labs
Work here? Claim this listing